Carbinoxamine / phenylephrine Pregnancy and Breastfeeding Warnings
Brand names: Aridex-D, Aridex-D Pediatric, HistamaxD, Norel LA, X-Hist, XiraHist
Carbinoxamine / phenylephrine Pregnancy Warnings
Carbinoxamine-phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Carbinoxamine-phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.
Carbinoxamine / phenylephrine Breastfeeding Warnings
There are no data on the excretion of carbinoxamine-phenylephrine into human milk. Because of the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- (2005) "Product Information. Norel LA (carbinoxamine-phenylephrine)." U.S. Pharmaceutical Corporation
References for breastfeeding information
- (2005) "Product Information. Norel LA (carbinoxamine-phenylephrine)." U.S. Pharmaceutical Corporation
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.